RCKT insider plans Rule 144 sale of 12,279 shares

An affiliate of RCKT filed a Rule 144 notice to sell 12,279 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $40,669.28.

Rhea-AI Filing Summary

An affiliate of RCKT filed a Rule 144 notice to sell 12,279 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $40,669.28. The shares were acquired via restricted stock vesting on 02/11/2026 and the approximate sale date is 02/13/2026.

The notice states that 108,222,228 shares of the issuer’s common stock were outstanding. Over the prior three months, the same seller disposed of 6,276 shares of common stock for gross proceeds of $18,720.05. The filer represents they are not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for RCKT disclose?

The Form 144 discloses a planned sale of 12,279 RCKT common shares under Rule 144. The shares, valued at $40,669.28, were acquired through restricted stock vesting on February 11, 2026 and are expected to be sold around February 13, 2026.

How many RCKT shares are being proposed for sale under this Form 144?

The filing indicates a proposed sale of 12,279 RCKT common shares. These shares are to be sold through Fidelity Brokerage Services LLC on the NASDAQ exchange, with an aggregate market value of $40,669.28 based on the figures in the notice.

How were the RCKT shares in this Form 144 acquired?

The 12,279 RCKT shares were acquired via restricted stock vesting from the issuer on February 11, 2026. The filing notes that payment was made in cash on the same date, indicating a standard equity compensation vesting event for the seller.

What does the Form 144 say about recent RCKT share sales by this seller?

Over the prior three months, the seller disposed of 6,276 RCKT common shares on November 18, 2025. Those shares generated $18,720.05 in gross proceeds, as reported in the section covering securities sold during the past three months.

How many RCKT shares were outstanding according to the Form 144?

The notice reports that 108,222,228 shares of RCKT common stock were outstanding. This figure provides a baseline for understanding the relative size of the 12,279-share planned sale described in the filing, though it does not change the sale terms themselves.

What representations does the seller make in the RCKT Form 144 filing?

The seller represents that they do not know of any undisclosed material adverse information about RCKT’s current or prospective operations. This representation is required when filing a Rule 144 notice for the proposed sale of restricted or control securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 03:55 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001725922
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROCKET PHARMACEUTICALS, INC.
SEC File Number	001-36829
Address of Issuer	350 FIFTH AVENUE SUITE 7530 NEW YORK NEW YORK 10118
Phone	646-440-9100
Name of Person for Whose Account the Securities are To Be Sold	Shah Gaurav
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	12279	40669.28	108222228	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Restricted Stock Vesting	issuer			12279	02/11/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gaurav Shah 9 Cedarbrook Drive Cranbury NJ 08512	Common	11/18/2025	6276	18720.05

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gaurav Shah
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)